Holdings

Birchview Capital, LP

As of Sep 30, 2026, Birchview Capital, LP reported 65 positions worth US$150M. Largest: KLA Corporation, Bristol-Myers Squibb Company and Lam Research Corporation. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
KLA Corporation167KUS$32.5M−11,533Sep 30, 2026
Bristol-Myers Squibb Company224KUS$14M−72,998Sep 30, 2026
Lam Research Corporation30,000US$9.86M−5,000Sep 30, 2026
Corcept Therapeutics Incorporated55,200US$6.36M−2,000Sep 30, 2026
Ovintiv Inc. (de)108KUS$6.22Mno changeSep 30, 2026
Ultragenyx Pharmaceutical Inc.374KUS$5.62MnewSep 30, 2026
Solid Biosciences Inc.716KUS$5.18M+49,759Sep 30, 2026
Protagonist Therapeutics, Inc.35,000US$4.93M−18Sep 30, 2026
Halozyme Therapeutics, Inc.33,351US$3.68M+100Sep 30, 2026
Stoke Therapeutics, Inc.138KUS$3.59M−40,110Sep 30, 2026